No Data
Express News | Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024
Navidea Biopharmaceuticals, Inc. Announces Special Meeting of Stockholders to Be Held July 8, 2024
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend Its SEC Reporting Obligations
Navidea Settles Litigation With Capital Royalty, Stock Rallies 30%
Navidea Biopharmaceuticals, CRG Settle All Ongoing Litigation
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
No Data
No Data
